Eledon Pharmaceuticals (ELDN) Shareholder's Equity Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.73% |
| Dec 31, 2025 | 50.50% |
| Sep 30, 2025 | -36.95% |
| Jun 30, 2025 | -30.41% |
| Mar 31, 2025 | -27.78% |
| Dec 31, 2024 | -27.52% |
| Sep 30, 2024 | -50.78% |
| Jun 30, 2024 | -33.13% |
| Mar 31, 2024 | -33.57% |
| Dec 31, 2023 | -31.12% |
| Sep 30, 2023 | 18.29% |
| Jun 30, 2023 | 67.25% |
| Mar 31, 2023 | 85.35% |
| Dec 31, 2022 | 35.96% |
| Sep 30, 2022 | 119.37% |
| Jun 30, 2022 | 110.43% |
| Mar 31, 2022 | 150.63% |
| Dec 31, 2021 | 124.51% |
| Sep 30, 2021 | 110.43% |
| Jun 30, 2021 | 102.46% |
| Mar 31, 2021 | 96.33% |
| Dec 31, 2020 | 113.98% |
| Sep 30, 2020 | 1.41% |
| Jun 30, 2020 | -26.37% |
| Mar 31, 2020 | -20.49% |
| Dec 31, 2019 | 76.55% |
| Sep 30, 2019 | -23.84% |
| Jun 30, 2019 | -25.57% |
| Mar 31, 2019 | -42.20% |
| Dec 31, 2018 | 73.35% |
| Sep 30, 2018 | -36.60% |
| Jun 30, 2018 | -36.18% |
| Mar 31, 2018 | -35.58% |
| Dec 31, 2017 | -42.72% |
| Sep 30, 2017 | -41.24% |
| Dec 31, 2016 | 63.43% |